Post by Takeda Oncology

We always value the opportunity to connect, share data and advance discussions across hematologic, thoracic and gastrointestinal cancers, and this year’s #ASCO2026 did not disappoint. Thank you to the oncology community, our partners and #TeamTakeda for the meaningful conversations and collaboration throughout the week. While ASCO may be over, the work continues as we push forward in our commitment to improving outcomes for patients.

Video Content